Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program
NCT ID: NCT02585362
Last Updated: 2019-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2016-03-31
2018-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Whey Protein Supplementation in Cancer Patients
NCT02065726
Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer
NCT06858449
Effect of Whey Protein Supplementation and Resistance Exercise on Muscle Parameters in Older Adults
NCT00635739
Whey Protein, Resistance Training, and Changes in Body Composition
NCT01186536
Feasibility and Effect of Resistance Training and Protein Supplementation in Patients With Advanced Gastroesophageal Cancer
NCT05650827
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Participants will receive physical exercise, nutrition counseling and a whey protein Supplement over 12 weeks
physical exercise
The standardized Training program will be performed twice a week in the Kantonsspital Winterthur and once a week in a home based setting
nutrition counseling
At least 3 times, participants will receive nutrition counseling to improve energy- and protein intake
whey protein supplement
On workout days study participants will consume twice a day 15 g of the supplement powder with approximately 150 ml water. On the remaining days participants consume the supplement once a day.
Control group
Participants will receive standard care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
physical exercise
The standardized Training program will be performed twice a week in the Kantonsspital Winterthur and once a week in a home based setting
nutrition counseling
At least 3 times, participants will receive nutrition counseling to improve energy- and protein intake
whey protein supplement
On workout days study participants will consume twice a day 15 g of the supplement powder with approximately 150 ml water. On the remaining days participants consume the supplement once a day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* WHO performance status ≥ 2
* Able to walk independently at least 100 meters
* Estimated life expectancy of ≥ 6 month
Exclusion Criteria
* Enteral or parenteral nutrition within 1 month
* History of ileus within 1 month
* Psychiatric disorder precluding understanding of information on trials related topics and giving informed consent
* Milk protein allergy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kantonsspital Winterthur KSW
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miklos Pless, Prof.
Role: PRINCIPAL_INVESTIGATOR
Kantonsspital Winterthur KSW
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kantonsspital Winterthur
Winterthur, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Leucine1.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.